Showing: 1 - 1 of 1 RESULTS
ADHD Briefing Clinical Trials LSD MindMed Phase 2 Psychedelics

Shroom Progress! MindMed Advances Towards a Phase 2 LSD Microdosing Trial For Adult ADHD

Aftermarket MindMed (NEO:MMED) announced they entered into a clinical trial agreement with Maastricht University to undertake a Phase 2a clinical trial for lysergic acid diethylamide (LSD) in adult patients with Attention Deficit Hyperactivity Disorder (ADHD). Artistic rendering courtesy of MindMed As per the agreement, Maastricht University will provide facilities and personnel for the Phase 2a Proof of Concept Clinical …